Cambrex is a small molecule company headquartered in East Rutherford, New Jersey, specializing in the research, development, and manufacture of small molecule therapeutics. Established in 1981, Cambrex offers a comprehensive range of services, including drug substance, drug product, and analytical services, catering to the pharmaceutical industry. The company possesses advanced technologies and capabilities such as biocatalysis, continuous flow processes, and solid-state science, alongside conventional dosage forms like oral solids, semi-solids, and liquids. Cambrex also produces specialized dosage forms, including modified-release and fixed-dose combination products, to support pharmaceutical companies in accelerating their drug development processes. With a dedicated team of experts, Cambrex is recognized for its reliability in both branded and generic markets.
Snapdragon Chemistry, Inc. specializes in continuous flow chemistry solutions tailored for the discovery and production of active pharmaceutical ingredients, intermediates, and materials. The company provides a range of services, including process development, reactor design and construction, portfolio optimization, and GMP manufacturing. By addressing the chemistry challenges faced by pharmaceutical, chemical, animal care, and material science sectors, Snapdragon Chemistry enables clients to create scalable synthetic processes. Founded in 2014 and based in Waltham, Massachusetts, the company was previously known as Firefly Chemistry, Inc. before rebranding in April 2015.
Q1 Scientific
Acquisition in 2022
Q1 Scientific specializes in providing environmentally controlled stability storage services tailored for the pharmaceutical, medical device, and life sciences sectors. The company offers outsourced stability storage and sample management solutions, ensuring a safe and secure environment for critical samples. By managing storage needs, Q1 Scientific helps accelerate the development of new drugs and reduces costs for companies that would otherwise need to invest in building and maintaining their own storage facilities.
Avista Pharma
Acquisition in 2018
Avista Pharma Solutions is a contract testing, development, and manufacturing organization that operates across three locations in Agawam, Massachusetts; Durham, North Carolina; and Longmont, Colorado. The company provides a wide range of services to clients in the pharmaceutical, animal health, and medical device sectors. These services include early drug development, active pharmaceutical ingredient (API) and drug product development, as well as compliant Good Manufacturing Practice (cGMP) manufacturing. Additionally, Avista offers standalone analytical and microbiology testing support, facilitating the development of newly created medicinal drugs. With over 200,000 square feet of laboratory and manufacturing space, Avista Pharma Solutions plays a vital role in the lifecycle of drug development and testing.
Halo Pharmaceutical
Acquisition in 2018
Halo Pharmaceutical, located in Whippany, New Jersey, specializes in contract dosage form development, manufacturing, and testing services for the pharmaceutical, biotechnology, and generic sectors. The company provides a comprehensive range of services that include the development and production of various dosage forms, such as tablets, capsules, powders, liquids, creams, and both sterile and nonsterile ointments and suppositories. By focusing on integrated capabilities, Halo Pharmaceutical aims to support its clients in advancing their products and ultimately improving patient outcomes.
PharmaCore
Acquisition in 2016
PharmaCore is a prominent partner in small molecule drug discovery, development, and manufacturing for pharmaceutical and biotechnology companies. The company provides a comprehensive range of services that align with the drug discovery process, offering advantages from lead discovery to lead optimization, chemical synthesis, and scale-up of pharmaceutical intermediates. PharmaCore excels in custom organic synthesis and produces active pharmaceutical ingredients using various chemistries. With GMP manufacturing facilities capable of scaling from grams to multi-kilogram quantities, the company operates eight GMP production areas equipped with reactors up to 2000 liters. PharmaCore's experienced Quality Assurance team ensures compliance with FDA and international regulations, while its state-of-the-art analytical services laboratories offer extensive testing capabilities and methods development. The company is also licensed to manufacture controlled substances and has expertise in logistics management for these regulated materials. Many clients leverage PharmaCore's skilled scientists as an extension of their own chemistry teams through both short and long-term contract research programs.
Xcellsyz
Acquisition in 2006
Xcellsyz is a biotechnology company, focusses on the discovery of new drugs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.